Thomas Beetham

Insider Reports History

Entity
Individual
Location
C/O Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton, Bermuda
Signature
/s/ Lara Meisner, Attorney-in-Fact for Thomas Beetham
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Beetham:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Magenta Therapeutics, Inc. Title: Chief Legal Officer and Secretary Common Stock 19.9K $239K $12.00 Nov 30, 2022 Direct
Viridian Therapeutics, Inc.\DE Chief Operating Officer Stock Option (Right to Buy) 474K Oct 30, 2023 Direct

Insider Reports Filed by Thomas Beetham

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VRDN Viridian Therapeutics, Inc.\DE Oct 30, 2023 0 $0 3 Nov 1, 2023 Chief Operating Officer
VRDN Viridian Therapeutics, Inc.\DE Oct 30, 2023 1 $0 4 Nov 1, 2023 Chief Operating Officer
MGTA Magenta Therapeutics, Inc. Nov 30, 2022 1 $2.82K 4 Dec 2, 2022 Title: Chief Legal Officer and Secretary
MGTA Magenta Therapeutics, Inc. Aug 1, 2022 1 $0 4 Aug 1, 2022 Title: Chief Legal Officer and Secretary
MGTA Magenta Therapeutics, Inc. May 31, 2022 1 $2.97K 4 Jun 6, 2022 Title: Chief Legal Officer and Secretary
MGTA Magenta Therapeutics, Inc. May 17, 2022 1 $0 4 May 19, 2022 Title: Chief Legal Officer and Secretary
MGTA Magenta Therapeutics, Inc. Feb 15, 2022 1 $0 4 Feb 17, 2022 Title: Chief Legal Officer and Secretary
MGTA Magenta Therapeutics, Inc. Sep 16, 2021 1 -$41.1K 4 Sep 20, 2021 Chief Legal Officer and Secretary
MGTA Magenta Therapeutics, Inc. Sep 14, 2021 1 $0 4 Sep 16, 2021 Chief Legal Officer and Secretary
MGTA Magenta Therapeutics, Inc. Jun 14, 2021 1 $0 4 Jun 15, 2021 Secretary and Chief Legal Officer
MGTA Magenta Therapeutics, Inc. Jun 14, 2021 0 $0 3 Jun 15, 2021 Secretary and Chief Legal Officer Exhibit 24.1: Power of Attorney